← Back to home
Digital Twin · Autoimmune Disease Monitoring

Sense. Simulate. Decide. Repeat.

A digital twin keeps a living, virtual model of a patient's immune activity in sync with joint imaging, inflammatory labs, and daily symptom data — then runs the simulations a quarterly rheumatology visit never has time for, so treatment decisions happen before a flare causes joint damage, not after. Walked through below using rheumatoid arthritis as the working example.

BEFORE THE LOOP STARTS

Building the Twin

JOINT IMAGING X-ray · ultrasound · MRI AUTOIMMUNE PROFILE & GENETICS RF & anti-CCP antibodies · HLA markers · family history TREATMENT & LIFESTYLE current DMARDs/biologics · baseline activity PERSONALIZED AUTOIMMUNE TWIN baseline model of this patient's joint inflammation & flare response
Before any monitoring starts, the twin needs a starting shape: imaging, autoimmune profile and genetics, and current treatment and lifestyle combine into a baseline virtual model. That baseline is what the continuous loop below keeps refined.
PHYSICAL — REAL PATIENT DIGITAL TWIN — VIRTUAL MODEL 1 PATIENT Lives their day — sensors ride along symptom diary · joint-swelling sensor 4 RHEUMATOLOGY TEAM Reviews the flagged trend, not raw data rheumatologist · rheumatology nurse 2 DIGITAL TWIN Virtual joint status, updated every reading inflammation & flare risk model 3 SIMULATION Tests several courses of action on the model 3 forecasts, ranked by risk continuous joint pain 4/10 · stiffness 45m NEW LAB / IMAGING e.g. CRP 18 mg/L runs parallel what-if scenarios continue DMARD? · steroid bridge? · escalate to biologic? FLARE? flare risk — alert sent stable — loop continues adjusted treatment plan & coaching
Two update paths feed the same twin: a continuous stream from a symptom diary and joint-swelling sensor, and a separate, dashed path for whenever a new lab result or joint image comes back — both land on the model, not just the initial build. The twin then simulates, checks the result against flare risk every cycle, and most cycles simply loop quietly; only real flare risk reaches the rheumatology team.
THE SAME LOOP, ZOOMED IN

Four Stages, Up Close

1

Sense

CRP 18 mg/L JOINT PAIN 4 / 10 MORNING STIFFNESS 45 min CRP — LAST 2 WEEKS now

One of the daily symptom-diary entries, plus periodic CRP labs and joint imaging feeding the same model on a slower cadence.

2

Model

INFLAMMATORY SENSITIVITY FLARE FREQUENCY RECOVERY AFTER FLARE population average this patient

The twin isn't a textbook patient — it's calibrated to how this one person's joints actually respond.

3

Simulate

NOW · DAY 4 continue DMARD — flare builds steroid bridge — quick control escalate biologic — gradual control

Every treatment option is tried on the model first. The full forecast is below.

4

Decide & act

ELEVATED RISK Suggest short steroid bridge starting today sends to app Steroid bridge suggested: 5-day taper

One alert, two audiences: the rheumatology team sees the risk, the patient sees the action.

STAGE 3, IN DETAIL

Where the Twin Pulls Ahead

The gauges above show why the twin's forecasts are personal. Here's the actual simulation it ran from a single day-4 CRP draw, testing three treatment courses against this patient's model before anyone committed to one.

The rheumatology team never sees the raw branching — only the ranked outcome, so their time goes to the decision, not the data.

normal band <10 mg/L 30 22 10 0 day 1 2 4 6 7 9 day 10 now · day 4
Actual reading Continue current DMARD Short steroid bridge Escalate to biologic
Illustrative simulation from one CRP draw — from the day-4 reading, the twin forecasts three plausible treatment paths so the rheumatology team compares outcomes, not raw numbers. Not real patient data.

Why the Loop Matters